Wang Lei, You Zhu-Hong, Huang De-Shuang, Li Jian-Qiang
IEEE Trans Cybern. 2023 Jan;53(1):67-75. doi: 10.1109/TCYB.2021.3090756. Epub 2022 Dec 23.
Clinical evidence began to accumulate, suggesting that circRNAs can be novel therapeutic targets for various diseases and play a critical role in human health. However, limited by the complex mechanism of circRNA, it is difficult to quickly and large-scale explore the relationship between disease and circRNA in the wet-lab experiment. In this work, we design a new computational model MGRCDA on account of the metagraph recommendation theory to predict the potential circRNA-disease associations. Specifically, we first regard the circRNA-disease association prediction problem as the system recommendation problem, and design a series of metagraphs according to the heterogeneous biological networks; then extract the semantic information of the disease and the Gaussian interaction profile kernel (GIPK) similarity of circRNA and disease as network attributes; finally, the iterative search of the metagraph recommendation algorithm is used to calculate the scores of the circRNA-disease pair. On the gold standard dataset circR2Disease, MGRCDA achieved a prediction accuracy of 92.49% with an area under the ROC curve of 0.9298, which is significantly higher than other state-of-the-art models. Furthermore, among the top 30 disease-related circRNAs recommended by the model, 25 have been verified by the latest published literature. The experimental results prove that MGRCDA is feasible and efficient, and it can recommend reliable candidates to further wet-lab experiment and reduce the scope of the experiment.
临床证据开始积累,表明环状RNA(circRNAs)可以成为各种疾病的新型治疗靶点,并在人类健康中发挥关键作用。然而,受circRNA复杂机制的限制,在湿实验室实验中难以快速大规模地探索疾病与circRNA之间的关系。在这项工作中,我们基于元图推荐理论设计了一种新的计算模型MGRCDA,以预测潜在的circRNA-疾病关联。具体而言,我们首先将circRNA-疾病关联预测问题视为系统推荐问题,并根据异质生物网络设计一系列元图;然后提取疾病的语义信息以及circRNA与疾病的高斯相互作用轮廓核(GIPK)相似性作为网络属性;最后,使用元图推荐算法的迭代搜索来计算circRNA-疾病对的得分。在金标准数据集circR2Disease上,MGRCDA的预测准确率达到92.49%,ROC曲线下面积为0.9298,显著高于其他现有最先进模型。此外,在该模型推荐的前30个与疾病相关的circRNA中,有25个已被最新发表的文献证实。实验结果证明MGRCDA是可行且高效的,它可以推荐可靠的候选者用于进一步的湿实验室实验,并缩小实验范围。